Avior Wealth Management LLC grew its holdings in Danaher Co. (NYSE:DHR – Free Report) by 17.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,750 shares of the conglomerate’s stock after buying an additional 2,305 shares during the period. Avior Wealth Management LLC’s holdings in Danaher were worth $4,379,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. CarsonAllaria Wealth Management Ltd. purchased a new stake in Danaher in the 2nd quarter valued at $25,000. nVerses Capital LLC purchased a new stake in shares of Danaher in the second quarter valued at about $25,000. MidAtlantic Capital Management Inc. acquired a new stake in Danaher during the third quarter worth about $40,000. MFA Wealth Advisors LLC purchased a new position in Danaher during the second quarter worth about $51,000. Finally, Financial Connections Group Inc. acquired a new position in Danaher in the 2nd quarter valued at about $51,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of recent analyst reports. Royal Bank of Canada cut their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. TD Cowen upped their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. Finally, Evercore ISI boosted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.
Danaher Trading Up 0.3 %
NYSE:DHR opened at $230.76 on Wednesday. Danaher Co. has a 12-month low of $207.63 and a 12-month high of $281.70. The firm has a market cap of $166.67 billion, a PE ratio of 44.04, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average price of $260.45 and a 200 day moving average price of $260.32.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.02 earnings per share. Sell-side analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current fiscal year.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s payout ratio is 20.61%.
Insider Transactions at Danaher
In related news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 10.90% of the company’s stock.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Dividend Payout Ratio Calculator
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What to Know About Investing in Penny Stocks
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- 3 Tickers Leading a Meme Stock Revival
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.